BridgeMD
Compares treatment options for Peripheral Lung Lesions
Official title Comparison of the Diagnostic Accuracy: US-guided Percutaneous Lung Biopsies vs CT-guided in Peripheral Lung Lesions
ClinicalTrials.gov ID: NCT06412289
What this study is testing
- What it's testing
- A non-sponsored prospective randomized single-blind national multicenter interventional study which aims to compare the diagnostic accuracy between US-guided percutaneous lung needle biopsies and CT-guided in peripheral lung lesions. Secondary endpoints are: onset of number and type of complications during and after the procedure, within the first three hour; exposition to ionizing radiation, in milligray(mGy); patient comfort during the procedure; duration of the procedure,
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Willingness and ability to provide free and informed consent. Age older then 18 years old.
- Peripheric pulmonary lesions adherent to the thoracic wall in CT scans with indication to typing
You likely can't join if
- Inability to provide free and informed consent, in the absence of an available legal guardian.
- Age younger then 18 years old.
- Terminal neoplastic diseases/ palliative care patients.
- Patients with one lung, anatomical of functional.
- Severe non-treatable blood clothing disfunctions.
- Severe organ failure (pulmonary, renal, hepatic or cardiac).
See the full eligibility criteria
- Willingness and ability to provide free and informed consent. Age older then 18 years old.
- Peripheric pulmonary lesions adherent to the thoracic wall in CT scans with indication to typing
- Inability to provide free and informed consent, in the absence of an available legal guardian.
- Age younger then 18 years old.
- Terminal neoplastic diseases/ palliative care patients.
- Patients with one lung, anatomical of functional.
- Severe non-treatable blood clothing disfunctions.
- Severe organ failure (pulmonary, renal, hepatic or cardiac).
- Women in state of pregnancy.
The study team makes the final eligibility decision.
Where it's taking place
- Ferrara, Italy
- Naples, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ferrara, Italy; Naples, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.